Development of a serum-free suspension process for the production of a conditionally replicating adenovirus using A549 cells

Cytotechnology

Volumn 49, Issue 2-3, 2005, Pages 161-171

  Longley Jr , Robert ^a   Radzniak, Laurie ^a   Santoro, Marc ^a   Tsao, Yung Shyeng ^a   Condon, Russell G G ^a   Lio, Peggy ^a   Voloch, Marcio ^a   Liu, Zhong ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

A549 cells; Adenovirus; Conditionally replicating adenoviruses (CRAVs); Gene therapy; Recombinant adenovirus; Serum free; Suspension

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ARTICLE; BIOREACTOR; CELL CULTURE; CELL LINE; CONTROLLED STUDY; GENETIC ENGINEERING; HUMAN; HUMAN CELL; LUNG CARCINOMA; SERUM; STATISTICAL SIGNIFICANCE; SUSPENSION; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADENOVIRIDAE; HUMAN ADENOVIRUS;

EID: 33745492034     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-006-0008-2     Document Type: Article

References (23)

1. JM Bergelson JA Cunningham G Droguett EA Kurt-Jones A Krithivas JS Hong MS Horwitz RL Crowell RW Finberg 1997 Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 Science 275 1320 1323
2. L Chu DK Robinson 2001 Industrial choices for protein production by large-scale cell culture Curr Opin Biotechnol 12 180 187
3. CJ Cohen JT Shieh RJ Pickles T Okegawa JT Hsieh JM Bergelson 2001 The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction Proc Natl Acad Sci USA 98 15191 15196
4. J Cote A Garnier B Massie A Kamen 1998 Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells Biotechnol Bioeng 59 567 575
5. M Dobbelstein 2004 Replicating adenoviruses in cancer therapy Curr Top Microbiol Immunol 273 291 334
6. D Farson TC Harding L Tao J Liu S Powell V Vimal S Yendluri K Koprivnikar K Ho C Twitty P Husak A Lin RO Snyder BA Donahue 2004 Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors J Gene Med 6 1369 1381
7. TB Ferreira AL Ferreira MJT Carrondo PM Alves 2005 Effect of re-feed strategies and non-ammoniagenic medium on adenovirus production at high cell densities J Biotechnol 119 3 272 280
8. A Garnier J Cote I Nadeau A Kamen B Massie 1994 Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells Cytotechnology 15 145 155
9. KH Hsu K Lonberg-Holm B Alstein RL Cromwell 1988 A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses J Virol 62 1647 1652
10. WS Hu JG Aunins 1997 Large-scale mammalian cell culture Curr Opin Biotechnol 8 148 153
11. P Iyer JM Ostrove D Vacante 1999 Comparison of manufacturing techniques for adenovirus production Cytotechnology 30 169 172
12. D Katayose P Seth 1999 Chapter 10: development of adenoviral vectors for gene therapy P Seth Adenoviruses: basic biology to gene therapy R.G. Landers Company Austin, TX 91 101
13. MJ [tmp] McConnell MJ Imperiale 2004 Biology of adenovirus and its use as a vector for gene therapy Human Gene Therapy 15 1022 1033
14. O Meier UF Greber 2004 Adenovirus endocytosis J Gene Med Suppl 1 S152 S163
15. DM Nettelbeck 2003 Virotherapeutics: conditionally replicative adenoviruses for viral oncolysis Anticancer Drugs 14 577 584
16. M Ramachandra A Rahman A Zou M Vaillancourt JA Howe D Antelman B Sugarman GW Demers H Engler D Johnson P Shabram 2001 Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy Nat Biotechnol 19 1035 1041
17. JM Siegfried YH Han MA DeMichele JD Hunt AL Gaither F Cuttitta 1994 Production of gastrin-releasing peptide by a non-small cell lung carcinoma cell line adapted to serum-free and growth factor-free conditions J Biol Chem 269 8596 8603
18. YS Tsao RG Condon EJ Schaefer DA Lindsay Z Liu 2000 Biomass and aggregation analysis of human embryonic kidney 293 suspension cell cultures by particle size measurement Biotechnol Prog 16 809 814
19. YS Tsao RG Condon EJ Schaefer P Lio Z Liu 2001 Development and improvement of a serum-free suspension process for the production of recombinant adenoviral vectors using HEK293 cells Cytotechnology 37 189 198
20. T Vincent RF Pettersson RG Crystal PL Leopold 2004 Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells J Virol 78 8047 8058
21. O Wildner 2003 Comparison of replication-selective, oncolytic viruses for the treatment of human cancers Curr Opin Mol Ther 5 351 361
22. KN Wills DC Maneval P Menzel MP Harris S Sutjipto MT Vaillancourt WM Huang DE Johnson SC Anderson SF Wen R Bookstein HM Shepard RJ Gregory 1994 Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer Hum Gene Ther 5 1079 1088
23. Y Zhang JM Bergelson 2005 Adenovirus receptors J Virol 79 12125 12131